Phibro Animal Health Co. (NASDAQ:PAHC - Free Report) - Stock analysts at Zacks Research decreased their Q1 2026 earnings per share estimates for Phibro Animal Health in a report released on Thursday, November 28th. Zacks Research analyst R. Department now forecasts that the company will post earnings per share of $0.31 for the quarter, down from their previous forecast of $0.32. The consensus estimate for Phibro Animal Health's current full-year earnings is $1.61 per share. Zacks Research also issued estimates for Phibro Animal Health's Q2 2026 earnings at $0.47 EPS, Q4 2026 earnings at $0.49 EPS and FY2026 earnings at $1.60 EPS.
Several other research firms also recently commented on PAHC. Barclays increased their target price on Phibro Animal Health from $13.00 to $20.00 and gave the company an "underweight" rating in a research report on Tuesday, November 12th. StockNews.com raised shares of Phibro Animal Health from a "buy" rating to a "strong-buy" rating in a report on Thursday. JPMorgan Chase & Co. began coverage on shares of Phibro Animal Health in a research note on Tuesday, September 10th. They set a "neutral" rating and a $22.00 price target for the company. Finally, Bank of America boosted their price objective on shares of Phibro Animal Health from $13.00 to $15.00 and gave the stock an "underperform" rating in a research note on Friday, August 30th. Three analysts have rated the stock with a sell rating, one has issued a hold rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, the company has an average rating of "Hold" and an average target price of $16.50.
View Our Latest Stock Report on PAHC
Phibro Animal Health Price Performance
Shares of PAHC traded up $0.17 during trading hours on Monday, reaching $23.54. The stock had a trading volume of 133,951 shares, compared to its average volume of 158,268. The stock has a market capitalization of $953.37 million, a PE ratio of 54.75, a PEG ratio of 0.60 and a beta of 0.51. Phibro Animal Health has a 12 month low of $9.94 and a 12 month high of $25.98. The company has a debt-to-equity ratio of 1.81, a quick ratio of 1.69 and a current ratio of 3.23. The company's 50-day moving average is $23.35 and its two-hundred day moving average is $20.27.
Phibro Animal Health Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Wednesday, December 18th. Investors of record on Wednesday, November 27th will be issued a $0.12 dividend. The ex-dividend date is Wednesday, November 27th. This represents a $0.48 annualized dividend and a yield of 2.04%. Phibro Animal Health's payout ratio is 111.63%.
Insider Buying and Selling at Phibro Animal Health
In related news, Director E Thomas Corcoran acquired 5,000 shares of the stock in a transaction dated Wednesday, September 4th. The stock was bought at an average price of $20.02 per share, for a total transaction of $100,100.00. Following the purchase, the director now directly owns 25,000 shares of the company's stock, valued at $500,500. The trade was a 25.00 % increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 50.07% of the company's stock.
Institutional Inflows and Outflows
A number of institutional investors have recently added to or reduced their stakes in PAHC. CWM LLC raised its holdings in Phibro Animal Health by 89.8% during the second quarter. CWM LLC now owns 2,188 shares of the company's stock worth $37,000 after buying an additional 1,035 shares during the last quarter. nVerses Capital LLC bought a new position in Phibro Animal Health in the 3rd quarter valued at about $70,000. Quantbot Technologies LP acquired a new position in Phibro Animal Health during the 3rd quarter valued at about $70,000. Summit Securities Group LLC bought a new stake in Phibro Animal Health during the 2nd quarter worth approximately $83,000. Finally, China Universal Asset Management Co. Ltd. raised its stake in shares of Phibro Animal Health by 63.7% in the third quarter. China Universal Asset Management Co. Ltd. now owns 3,912 shares of the company's stock worth $88,000 after purchasing an additional 1,522 shares during the last quarter. 99.34% of the stock is owned by institutional investors and hedge funds.
Phibro Animal Health Company Profile
(
Get Free Report)
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.
Read More
Before you consider Phibro Animal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Phibro Animal Health wasn't on the list.
While Phibro Animal Health currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
